TL;DR
This study investigated the gut microbiome of children with hyperuricemia (HUA), finding distinct microbial compositions compared to healthy controls. The research suggests that alterations in gut bacteria involved in producing short-chain fatty acids (SCFAs) and sulfides may contribute to HUA, opening avenues for potential microbiome-targeted therapies.
What Problem Does This Paper Address?
Hyperuricemia (HUA), characterized by elevated serum uric acid levels, is a known risk factor for various health issues, including hypertension and kidney disease, even in adults. While gut dysbiosis (an imbalance in the gut microbiome) has been implicated in the pathogenesis of gout (a severe form of hyperuricemia) in adults, its role in children with HUA, particularly in the absence of clinical gout, remains largely unexplored. This paper aims to fill this knowledge gap by characterizing the gut microbiota in children with HUA and identifying potential microbial associations that could explain the observed differences. Understanding these early-life microbial signatures could be crucial for developing preventative or therapeutic strategies for HUA.
Methods
The study employed a case-control design, recruiting 80 children aged 5-15 years, divided into HUA (n=40) and control (Con, n=40) groups based on serum uric acid levels.
- 16S rRNA High-Throughput Sequencing: Fecal samples were collected to extract DNA, and the V3-V4 hypervariable regions of the 16S rRNA gene were amplified and sequenced using Illumina MiSeq. This is a standard method for profiling bacterial communities.
- Bioinformatics Analysis: Raw sequencing data was processed using QIIME2 for quality filtering, denoising (DADA2), and amplicon sequence variant (ASV) identification. Phylogenetic trees were constructed, and ASVs were taxonomically classified against the Greengene database.
- Diversity Analysis: Alpha-diversity (within-sample diversity) and beta-diversity (between-sample diversity) were assessed using various metrics (Shannon diversity index, observed OTUs, Faith's phylogenetic diversity, Pielou's evenness, Bray-Curtis distance, Jaccard distance, Unweighted-unifrac, and Weighted-unifrac). Principal Coordinate Analysis (PCoA) was used to visualize beta-diversity.
- Differential Abundance Analysis: Mann-Whitney U-tests were used to compare the relative abundances of phyla and genera between the HUA and Con groups. LEfSe (Linear Discriminant Analysis Effect Size) was employed to identify differentially abundant taxa.
- Microbial Biomarker Identification: Discriminant analysis (DA) was performed to identify microbial biomarkers capable of distinguishing between the HUA and Con groups. Receiver Operating Characteristic (ROC) curves were used to evaluate the discriminatory power of these biomarkers.
- Metabolic Pathway Prediction: PICRUSt2 was used to predict the functional potential of the gut microbiota based on 16S rRNA gene data, inferring KEGG pathways.
Datasets
Not discussed in the paper.
Key Insights and Ideas
- Gut Microbiota Distinctness in HUA Children: The study provides the first evidence that the gut microbiota composition differs significantly between children with HUA and healthy controls, even in the absence of clinical gout. This suggests that HUA may have an early microbial signature.
- Beta-Diversity Shift: While alpha-diversity showed no significant difference, beta-diversity analysis revealed a clear separation between the HUA and Con groups, indicating that the overall community structure of the gut microbiota is altered in HUA.
- Specific Bacterial Signatures: The HUA group showed an enrichment of Proteobacteria and genera like Actinomyces and Streptococcus, while the Con group had higher abundances of Bacteroidetes and genera such as Alistipes and Bilophila.
- SCFA and Sulfide Producers as Potential Contributors: The negative correlation between serum UA and SCFA-producing bacteria (Alistipes, Faecalibacterium, Oscillospira) and sulfidogenic bacteria (Bilophila) is a key finding. This suggests that a reduction in beneficial SCFA production and potentially altered sulfide metabolism might be linked to HUA.
- Altered Purine Metabolism Pathways: Functional predictions indicated a decrease in pathways related to purine nucleotide de novo biosynthesis and an increase in purine deoxyribonucleoside degradation in HUA subjects, hinting at a potential link between gut microbial metabolism of purines and uric acid levels.
Key Results
- Demographics: The HUA group had significantly higher age, BMI, and serum UA levels compared to the Con group.
- Microbial Composition:
- At the phylum level, Proteobacteria was increased and Bacteroidetes was decreased in the HUA group (p < 0.05).
- At the genus level, Actinomyces and Streptococcus were more prevalent in HUA subjects, while Alistipes and Bilophila were more prevalent in Con subjects (p < 0.05).
- Correlations: Serum UA positively correlated with Actinomyces, Morganella, and Streptococcus, and negatively correlated with Alistipes, Bilophila, Faecalibacterium, Oscillospira, Parabacteroides, and Phascolarctobacterium.
- Biomarker: The genus Bilophila showed a good discriminatory power (AUC = 0.720) for identifying Con subjects.
- Metabolic Pathways: The superpathways of purine nucleotide de novo biosynthesis were decreased, and the superpathway of purine deoxyribonucleosides degradation was increased in HUA subjects (p < 0.05).
Limitations and Future Work
- Causality: The study is cross-sectional, meaning it cannot establish a causal relationship between the observed gut microbiota alterations and HUA.
- Geographic and Dietary Specificity: The study population was limited to a specific region, and diverse diets and environments could influence gut microbiota composition. The authors suggest that multicenter studies with diverse populations are needed.
- Confounding Factors: While efforts were made to control for certain factors, the influence of diet (e.g., fructose intake), genetics, and other lifestyle factors on the gut microbiome and UA levels cannot be fully excluded. The authors acknowledge that obesity, prevalent in their study population, is a significant confounding factor.
- Future Directions: The findings suggest that targeting the gut microbiota, particularly those involved in SCFA and sulfide production, could be a promising avenue for future therapeutic strategies for HUA. Further research, including experimental studies and longitudinal designs, is needed to confirm these hypotheses and explore specific interventions.
Summary updated